Navigation Links
GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
Date:8/13/2011

nts. The results from millions of in silico simulations of these models will provide unique insights into the fundamental mechanisms of NSCLC and its response to drug treatments, enabling the development of more effective treatments for NSCLC.

The initial phase of this project is also intended to help GNS and NCI develop standards for the exchange of data to conduct future collaborations in other relevant mouse model systems.  From this starting point, the groups envision the possibility of a combined experimental and computational work flow aimed at rapidly enabling the generation of hypotheses, testing these hypothesis in silico and in vivo, generating new confirmatory data, and rapidly cycling back to additional computational modeling, with the goal of accelerating the conversion of knowledge into new clinical options for cancer patients.  

About REFS(TM)

REFS(TM) is comprised of integrated machine learning algorithms and software that extract "causal" relationships from complex, multi-dimensional data and enable the simulation of billions of "what if?" hypotheses to explore novel unseen conditions and predictions forward in time. This model-centric discovery and simulation approach represents a paradigm shift in data analysis, leapfrogging existing approaches such as high-dimensional pattern matching. REFS(TM) is licensed to GNS Healthcare from Via Science.

About GNS Healthcare, Inc.

GNS Healthcare (www.gnshealthcare.com), a subsidiary of Via Science, is a healthcare IT company that applies machine learning and simulation technology to optimize patient treatment in partnership with health insurance companies, pharmacy benefit managers, and pharmaceutical & biotech companies. GNS Healthcare is the leading "big data" healthcare analytics firm between drug makers and drug buyers, matching treatments to patients to deliver on the promise of "smart" medic
'/>"/>

SOURCE GNS Healthcare, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology news :

1. GE Healthcare studies report results of [18F]Flutemetamol research
2. GNS Healthcare Collaborates with NCI in New Approach to Lung Cancer; Supercomputer Analysis to Aid in Matching Targeted Drugs to Patients
3. New Healthcare Franchise Opportunity Focuses on Treating Exploding Senior Population
4. Corning, GE Healthcare to receive Technical Achievement Award from Ceramic Society
5. Lexicon to Present Clinical Data for Diabetes Drug Candidate, LX4211, at Two Major Healthcare Conferences
6. Inventor honored for tech improving access to clean water, healthcare, and business development in India
7. The Full Yield, Inc. Launches Breakthrough Collaboration to Put Food Back at the Heart of Healthcare
8. TGen-Scottsdale Healthcare researchers make breakthrough in lung cancer
9. GE Healthcare to evaluate and develop novel imaging technology
10. Scott & White Healthcare researcher finds success with new anti-cancer drug
11. Scott & White Healthcare researcher finds success with new anti-cancer drug
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/29/2015)... 24, 2015 Research and ... "Latin America Biomedical Sensors Market - Growth, Trends ... The Latin America Biomedical Sensors market is estimated ... 2.04% over the period 2014-2020 The near ... the genetic formulation of each individual. These sensors can ...
(Date:6/24/2015)... , June 24, 2015 The biologics safety ... major drivers for the market include growth of the ... new drug launches. Over the years, the number of ... 2001 and 2010, the FDA approved 225 drug applications ... WIPO, Europe accounted for 3,822 ...
(Date:6/23/2015)... , June 23, 2015   MedNet Solutions ... supports the entire spectrum of clinical research, is ... ™ , the company,s intuitive, flexible and ... a Silver 2015 Stevie® Award by the ... & Services Website category.  The American Business Awards ...
Breaking Biology News(10 mins):Latin America Biomedical Sensors Market Report 2015-2020 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 2Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 3Biological Safety Testing Market by Application, Product, & Test - Global Forecast to 2019 4MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
... CORVALLIS, Ore. A laboratory study has shown for the ... are linked to a side-effect of some statin drugs - ... of the most widely prescribed drugs in the world, able ... of heart attacks or other cardiovascular events. However, their role ...
... dozen Ludwig scientists from around the world presented the ... this week,s American Association for Cancer Research (AACR) Annual ... program with important diagnostic and treatment implications for emerging ... available to help patients with melanoma, researchers are developing ...
... age at which a child with autism is diagnosed ... he or she exhibits, new research from the University ... poor nonverbal communication and repetitive behaviors, were associated with ... a study in the April issue of the ...
Cached Biology News:Co-Q10 deficiency may relate to concern with statin drugs, higher risk of diabetes 2Ludwig presents advancements in immunotherapy and epigenetics at the American Association for Cancer Research Annual Meeting 2In autism, age at diagnosis depends on specific symptoms 2
(Date:7/1/2015)... TRIANGLE PARK, N.C. and ... agricultural research firm AgBiome, and Genective, key developer ... to accelerate the discovery of new generations of ... traits for insect control to counter the realities ... partner with Genective, aligning AgBiome,s unique insect control ...
(Date:7/1/2015)... , July 1, 2015   Neuraltus ... the development of groundbreaking drugs to treat neurodegenerative ... today that Robert G. Miller , M.D., Director ... Sutter Health,s California Pacific Medical Center in San Francisco, ... Association for $1.5 million to help fund a ...
(Date:7/1/2015)... 2015 InferMed , ... will augment ... clinical s olutions suite   Elsevier ... products and services, announced today the acquisition of  InferMed , ... technology company. InferMed,s Arezzo technology supports clinicians in ...
(Date:6/30/2015)... Japan , July 1, 2015 R-Japan Co.,Ltd. ... on the Safety of Regenerative Medicine from the Ministry of ... on June 29, 2015. The fact that ... processing facility through the auditing from Pharmaceuticals and Medical Devices ... the application, allows it to provide stem cell manufacturing service ...
Breaking Biology Technology:AgBiome and Genective collaborate to create novel insect-resistant crops 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 2Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 3Investigator to Receive $1.5 Million Grant from the ALS Association to Help Fund Confirmatory Phase 2 Study of Neuraltus Pharmaceuticals' NP001 4Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 2Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 3Elsevier Acquires InferMed, Provider of Clinical Decision Support Technology 4R-Japan Obtained Autologous Stem Cell Manufacturing License from the Ministry of Health, Labour and Welfare 2
... , PALO ALTO, Calif., Aug. 17, 2009 ... with a focus on the NS4B Hepatitis C Virus (HCV) ... Board of Directors. , , Truex is ... private pharmaceutical company focused on the development of anti-inflammatory products ...
... , SAN DIEGO, Aug. 17 Imagenetix, ... natural-based, proprietary products announced that last week Dr. Robert Hesslink, ... on his Bloomberg Radio program, Taking Stock. Dr. Hesslink ... its flagship product, InflameAway Celadrin(R), and 1-TDC, Imagenetix,s early stage ...
... Inc. (NASDAQ: VSGN ; TSX:VAS), today announced that ... Department of The NASDAQ Stock Market indicating that Vasogen ... We plan to request a hearing before the NASDAQ ... determination of the continued listing of our common stock. ...
Cached Biology Technology:Eiger BioPharmaceuticals Appoints Paul Truex to Board of Directors 2Imagenetix, Inc. Announces Interview With Bloomberg Radio 2Vasogen Receives NASDAQ Notification Related to Minimum Bid Price 2